Mackenzie Financial Corp Guardant Health, Inc. Transaction History
Mackenzie Financial Corp
- $65.9 Billion
- Q1 2025
A detailed history of Mackenzie Financial Corp transactions in Guardant Health, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 7,526 shares of GH stock, worth $414,682. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,526
Previous 7,526
-0.0%
Holding current value
$414,682
Previous $229,000
39.74%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding GH
# of Institutions
404Shares Held
125MCall Options Held
1.47MPut Options Held
2.39M-
Vanguard Group Inc Valley Forge, PA12.2MShares$670 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$619 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$300 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$284 Million0.04% of portfolio
-
Baillie Gifford & CO4.81MShares$265 Million0.2% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.63B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...